ES2121748T3 - Compuestos para el tratamiento de la enfermedad inflamatoria del intestino. - Google Patents

Compuestos para el tratamiento de la enfermedad inflamatoria del intestino.

Info

Publication number
ES2121748T3
ES2121748T3 ES90313923T ES90313923T ES2121748T3 ES 2121748 T3 ES2121748 T3 ES 2121748T3 ES 90313923 T ES90313923 T ES 90313923T ES 90313923 T ES90313923 T ES 90313923T ES 2121748 T3 ES2121748 T3 ES 2121748T3
Authority
ES
Spain
Prior art keywords
bencilo
substituted
intestine
compounds
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90313923T
Other languages
English (en)
Inventor
Jaswant Singh Gidda
Jill Ann Panetta
Michael Leroy Phillips
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of ES2121748T3 publication Critical patent/ES2121748T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/14—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/36—Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Surgical Instruments (AREA)
  • Nonmetallic Welding Materials (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Eye Examination Apparatus (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

SE REVELA UN METODO PARA TRATAR ENFERMEDADES DE INTESTINO INFLAMADO EN MAMIFEROS UTILIZANDO CIERTOS DERIVADOS DE RODAMINA SUSTITUIDA DE BENCILO. TAMBIEN SE REVELAN NUEVOS DERIVADOS DE RODANINA SUSTITUIDA DE BENCILO, UN PROCESO PARA SU PRODUCCION Y SUS COMPOSICIONES FARMACEUTICAS. ADEMAS SE REVELA UN NUEVO PROCESO PARA AISLAR SELECTIVAMENTE EN FORMA ENANTIOMERICA SUSTANCIALMENTE PARA LOS ENANTIOMEROS DE CIERTOS DERIVADOS RACEMICOS DE RODAMINA SUSTITUIDA DE BENCILO.
ES90313923T 1989-12-21 1990-12-19 Compuestos para el tratamiento de la enfermedad inflamatoria del intestino. Expired - Lifetime ES2121748T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US45420389A 1989-12-21 1989-12-21

Publications (1)

Publication Number Publication Date
ES2121748T3 true ES2121748T3 (es) 1998-12-16

Family

ID=23803709

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90313923T Expired - Lifetime ES2121748T3 (es) 1989-12-21 1990-12-19 Compuestos para el tratamiento de la enfermedad inflamatoria del intestino.

Country Status (22)

Country Link
EP (1) EP0434394B1 (es)
JP (1) JP3036853B2 (es)
KR (1) KR0176243B1 (es)
CN (1) CN1029846C (es)
AT (1) ATE169294T1 (es)
AU (1) AU639734B2 (es)
CA (1) CA2032330C (es)
CY (1) CY2100B1 (es)
DE (1) DE69032537T2 (es)
DK (1) DK0434394T3 (es)
ES (1) ES2121748T3 (es)
FI (2) FI104251B1 (es)
HU (1) HU216732B (es)
IE (1) IE904633A1 (es)
IL (3) IL108962A (es)
MX (1) MX23803A (es)
NO (1) NO300458B1 (es)
NZ (1) NZ236472A (es)
PT (1) PT96198B (es)
RU (2) RU2036915C1 (es)
YU (1) YU240690A (es)
ZA (1) ZA9010041B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU87339A1 (fr) * 1988-09-20 1990-04-06 Oreal Nouveaux derives de benzylidene-cyclanones,leur procede de preparation,leur utilisation en tant qu'agents anti-oxydants et comme filtres solaires,compositions cosmetiques et pharmaceutiques les contenant
US5143928A (en) * 1990-03-27 1992-09-01 Warner-Lambert Company 3,5-di-tertiarybutyl-4-hydroxyphenylmethylene derivatives of 2-substituted thiazolidinones, oxazolidinones, and imidazolidinones as antiinflammatory agents
EP0915090A1 (en) * 1992-09-10 1999-05-12 Eli Lilly And Company Compounds useful as hypoglycemic agents and for treating Alzheimer's disease
ATE135697T1 (de) * 1992-10-28 1996-04-15 Shionogi & Co Benzylidenderivate
US6251928B1 (en) * 1994-03-16 2001-06-26 Eli Lilly And Company Treatment of alzheimer's disease employing inhibitors of cathepsin D
US5563277A (en) * 1994-12-21 1996-10-08 Eli Lilly And Company Process for preparing benzyl-substituted rhodanine derivatives
DK0761657T3 (da) * 1995-09-07 2000-08-14 Lilly Co Eli Fremgangsmåde til fremstilling af benzylsubstituerede rhodaninderivater
AR003483A1 (es) * 1995-09-07 1998-08-05 Lilly Co Eli Procedimiento para preparar y aislar la forma ii de la (±)-5-[3,5-bis(1,1- dimetil)-4-hidroxifenil)-metil)-4-tiazolidinona.
EP0779282A1 (en) * 1995-12-14 1997-06-18 Eli Lilly And Company Thiomorpholinone compounds for treating multiple sclerosis
US5981523A (en) * 1996-02-05 1999-11-09 Eli Lilly And Company Compounds and methods for treating multiple sclerosis
US5773455A (en) * 1996-06-28 1998-06-30 Biomeasure, Incorporated Inhibitors of prenyl transferases
US6005142A (en) * 1996-09-03 1999-12-21 Eli Lilly And Company Process for preparing benzyl-substituted rhodanine derivatives
US6063799A (en) * 1996-09-03 2000-05-16 Eli Lilly And Company Alternate crystal form of Tazofelone
EP1117655A1 (en) 1998-09-30 2001-07-25 Angelika Esswein Rhodanine carboxylic acid derivatives for the treatment and prevention of metabolic bone disorders
WO2000018748A1 (en) * 1998-09-30 2000-04-06 Roche Diagnostics Gmbh Rhodanine derivatives for the treatment and prevention of metabolic bone disorders
AU6331099A (en) * 1998-09-30 2000-04-17 Roche Diagnostics Gmbh Thiazolidine derivatives for the treatment and prevention of metabolic bone disorders
US7235573B2 (en) 2002-09-30 2007-06-26 The Regents Of The University Of California Methods of treating secretory diarrhea using cystic fibrosis transmembrane conductance regulator protein inhibitors
BR0314943A (pt) * 2002-09-30 2005-08-02 Univ California Inibidores da proteìna reguladora da condutância transmembrana da fibrose cìstica e usos destes
AU2002953533A0 (en) * 2002-12-24 2003-01-16 Arthron Limited Fc receptor modulating compounds and compositions
JP5778755B2 (ja) * 2010-04-15 2015-09-16 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ Ｇｅｓｅｌｌｓｃｈａｆｔ ｍｉｔ ｂｅｓｃｈｒａｅｎｋｔｅｒ Ｈａｆｔｕｎｇ ヒドロキノンの製造方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL79648A (en) * 1985-08-09 1991-12-12 Lilly Co Eli Pharmaceutical anti-inflammatory and ischemia preventing compositions containing di-t-butylphenol derivatives,some such novel compounds and process for their preparation
IE62214B1 (en) * 1988-05-25 1995-01-11 Warner Lambert Co Arylmethylenyl derivatives of thiazolidinones, imidazolidinones and oxazolidinones useful as antiallergy agents and antiinflammatory agents
ES2088965T3 (es) * 1989-04-07 1996-10-01 Lilly Co Eli Derivados de rodanina aril-sustituidos.

Also Published As

Publication number Publication date
DE69032537D1 (de) 1998-09-10
YU240690A (sh) 1992-12-21
EP0434394A2 (en) 1991-06-26
FI19991698A7 (fi) 1999-08-10
MX23803A (es) 1994-02-28
FI19991698L (fi) 1999-08-10
FI906273A0 (fi) 1990-12-19
IL108962A0 (en) 1994-06-24
DE69032537T2 (de) 1999-01-21
FI104251B (fi) 1999-12-15
HU908368D0 (en) 1991-07-29
IL108962A (en) 1996-12-05
HU216732B (hu) 1999-08-30
IE904633A1 (en) 1991-07-17
AU6826690A (en) 1991-06-27
JP3036853B2 (ja) 2000-04-24
CY2100B1 (en) 2002-04-05
CN1029846C (zh) 1995-09-27
RU2050355C1 (ru) 1995-12-20
JPH04279573A (ja) 1992-10-05
NO905478D0 (no) 1990-12-19
NO905478L (no) 1991-06-24
CN1052668A (zh) 1991-07-03
EP0434394A3 (en) 1992-01-08
PT96198A (pt) 1991-09-30
DK0434394T3 (da) 1998-12-14
ZA9010041B (en) 1992-08-26
PT96198B (pt) 1998-05-29
NZ236472A (en) 1993-03-26
ATE169294T1 (de) 1998-08-15
FI906273L (fi) 1991-06-22
CA2032330A1 (en) 1991-06-22
NO300458B1 (no) 1997-06-02
AU639734B2 (en) 1993-08-05
CA2032330C (en) 2001-05-08
FI104251B1 (fi) 1999-12-15
IL96654A (en) 1995-06-29
KR910011812A (ko) 1991-08-07
EP0434394B1 (en) 1998-08-05
RU2036915C1 (ru) 1995-06-09
HUT59915A (en) 1992-07-28
KR0176243B1 (ko) 1999-03-20

Similar Documents

Publication Publication Date Title
ES2121748T3 (es) Compuestos para el tratamiento de la enfermedad inflamatoria del intestino.
ES2071930T3 (es) Procedimiento para tratar la enfermedad inflamatoria intestinal.
PT98393A (pt) Processo para a preparacao de derivados de quinuclidina
ES2159851T3 (es) Amidas de acidos aminotiofenocarboxilicos y su empleo como inhibidores de la fosfodiestearasa.
PT99794A (pt) Processo para a preparacao de novas piperazinas 1,4-dissubstituidas
AT385036B (de) Verfahren zum herstellen von neuen carboxamidoderivaten von 5h-1,3,4-thiadiazolo(3,2-a)-pyrimidinen und ihren pharmazeutisch unbedenklichen salzen
EP1399151A4 (en) METHOD FOR TREATING INFLAMMABLE DISEASES BY ADMINISTRATING A PPAR DELTA AGONIST
IT1154024B (it) Derivati pridinici e procedimento per la loro produzione
PT69618A (de) Neue imidazolderivate verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praparate
BE870855A (fr) Procede pour l'isolement d'acides organiques
ES545194A0 (es) Un procedimiento para preparar derivados de purina
ES2039196T3 (es) Procedimiento para preparar 4-(1,2,5,6-tetrahidro-1-alquil-3-piridinil)-2-tiazolaminas y 4-(hexahidro-1-alquil-3-piridinil)-2-tiazolaminas.
DE69130679D1 (de) Die herstellung von zusammensetzungen zur behandlung von krankheiten der zellproliferation
HUT44933A (en) Process for preparing pharmaceuticals comprising carboxylic acidamides suitables for treating inflammatory and rheumatic diseases
ES2167721T3 (es) Utilizacion de 1-hidroxi-2-piridonas para el tratamiento de la dermatitis seborreica.
SE7605204L (sv) Neuroleptika
ES2173177T3 (es) Compuestos alcaloides indol diterpeno.
ES2181809T3 (es) Procedimiento para preparar derivados de rodanina sustituidos con bencilo.
CS53688A2 (en) Method of new substituted 3-phenyl-7h-thiazolo/3,2-b//1,2,4/triazine -7-ons production
BR9503832A (pt) Composição farmacêutica de nizatidina processo para prepação de uma forma de nizatidina e forma de nizatidina assim preparada
ES2089503T3 (es) Nuevos nitrilos del acido 1-aril-4-piperazinil-ciclohexanocarboxilico, su obtencion y empleo.
ES2061689T3 (es) Produccion de derivados de 2,3'-anhidro-2'-desoxiuridina.
FR2427334A1 (fr) Derives de dibenzothiepine, leur procede de preparation et leur application en therapeutique
FR2845992B1 (fr) Derives de 3-(cyclopenten-1yl)-benzyl-ou3-(cyclopenten-1yl)- heteroarylmethyl-amines et leur utilisation a titre de medicaments pour le traitement de la schizophrenie
FR2521164B1 (fr) Procede pour la production de kallikreine humaine

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 434394

Country of ref document: ES